IntelGenx Technologies (IGXT) 10-Q 14 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	13-May-15
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Trading Symbol	igxt
Entity Registrant Name	IntelGenx Technologies Corp.
Entity Central Index Key	1098880
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		63,465,256
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Consolidated_Balance_Sheet

Consolidated Balance Sheet (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current
Cash and cash equivalents	$3,819	$4,399
Accounts receivable	76	652
Prepaid expenses	72	96
Investment tax credits receivable	122	108
Total Current Assets	4,089	5,255
Leasehold Improvements and Equipment, net	1,361	983
Intangible Assets	25	46
Security Deposit	237	0
Total Assets	5,712	6,284
Current
Accounts payable and accrued liabilities	245	466
Current portion of term loan	39	0
Deferred license revenue	856	1,245
Total Current Liabilities	1,140	1,711
Term Loan	356	0
Total Liabilities	1,496	1,711
Shareholders' Equity
Capital Stock	1	1
Additional Paid-in-Capital	22,674	22,654
Accumulated Deficit	-17,902	-17,848
Accumulated Other Comprehensive Loss	-557	-234
Total Shareholders' Equity	4,216	4,573
Total Liabilities and Stockholders' Equity	$5,712	$6,284

Consolidated_Statement_of_Shar

Consolidated Statement of Shareholders' Equity (USD $)	Capital Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income [Member]	Total
In Thousands, except Share data
Beginning Balance at Dec. 31, 2014	$1	$22,654	($17,848)	($234)	$4,573
Beginning Balance (Shares) at Dec. 31, 2014	63,465,255
Foreign currency translation adjustment				-323	-323
Stock-based compensation		20			20
Net loss for the period			-54		-54
Ending Balance at Mar. 31, 2015	$1	$22,674	($17,902)	($557)	$4,216
Ending Balance (Shares) at Mar. 31, 2015	63,465,255

Consolidated_Statement_of_Comp

Consolidated Statement of Comprehensive Loss (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenues
Royalties	$234	$97
License and other revenue	391	125
Total Revenues	625	222
Expenses
Cost of royalty and license revenue	84	0
Research and development expense	117	188
Selling, general and administrative expense	393	460
Depreciation of tangible assets	7	7
Amortization of intangible assets	9	9
Total Expenses	610	664
Operating income (loss)	15	-442
Interest income	10	0
Financing and Interest expense	-79	0
Net Loss	-54	-442
Other Comprehensive Loss
Foreign currency translation adjustment	-323	-231
Comprehensive Loss	($377)	($673)
Basic and Diluted Weighted Average Number of Shares Outstanding	63,465,255	62,064,139
Basic and Diluted Loss Per Common Share	$0	($0.01)

Consolidated_Statement_of_Cash

Consolidated Statement of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Funds Provided - Operating Activities
Net loss	($54)	($442)
Amortization and depreciation	16	16
Stock-based compensation	20	32
Total adjustments	-18	-394
Changes in assets and liabilities:
Accounts receivable	576	118
Prepaid expenses	24	41
Investment tax credits receivable	-14	-17
Security deposit	-237	0
Accounts payable and accrued liabilities	-221	-309
Deferred revenue	-389	-27
Net change in assets and liabilities	-261	-194
Net cash used by operating activities	-279	-588
Financing Activities
Proceeds from exercise of warrants	0	1,064
Net cash provided by financing activities	395	1,064
Issuance of term loans	395	0
Investing Activities
Additions to property and equipment	-384	-105
Net cash used in investing activities	-384	-105
Increase (Decrease) in Cash and Cash Equivalents	-268	371
Effect of Foreign Exchange on Cash and Cash Equivalents	-312	-210
Cash and Cash Equivalents
Beginning of Period	4,399	5,005
End of Period	$3,819	$5,166

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Basis of Presentation [Text Block]	1	Basis of Presentation
		The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature.
		These financial statements should be read in conjunction with the audited consolidated financial statements at December 31, 2014. Operating results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). This basis of accounting involves the application of accrual accounting and consequently, revenues and gains are recognized when earned, and expenses and losses are recognized when incurred.
		The consolidated financial statements include the accounts of the Company and its subsidiary companies. On consolidation, all inter-entity transactions and balances have been eliminated.
		The financial statements are expressed in U.S. funds.
		Management has performed an evaluation of the Company’s activities through the date and time these financial statements were issued and concluded that there are no additional significant events requiring recognition or disclosure.

Adoption_of_New_Accounting_Sta

Adoption of New Accounting Standards	3 Months Ended
	Mar. 31, 2015
Adoption of New Accounting Standards [Text Block]	2	Adoption of New Accounting Standards
		The FASB issued ASU No. 2014-08 which enhances convergence between U.S. GAAP and International Financial Reporting Standards (IFRS). The amendments in the ASU change the criteria for reporting discontinued operations while enhancing disclosures in this area. It also addresses sources of confusion and inconsistent application related to financial reporting of discontinued operations guidance in U.S. GAAP. Under the new guidance, only disposals representing a strategic shift in operations should be presented as discontinued operations. Those strategic shifts should have a major effect on the organization’s operations and financial results. Examples include a disposal of a major geographic area, a major line of business, or a major equity method investment. In addition, the new guidance requires expands disclosures about discontinued operations that will provide financial statement users with more information about the assets, liabilities, income, and expenses of discontinued operations. The amendments in the ASU were effective in the first quarter of 2015 for public organizations with calendar year ends. The adoption of this Statement did not have a material effect on the Company`s financial position or results of operations.

Significant_Accounting_Policie

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Significant Accounting Policies [Text Block]	3	Significant Accounting Policies
		Recently Issued Accounting Pronouncements
		ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis
		The amendments in ASU 2015-02 are intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures. The new standard reduces the number of consolidation models and improves current GAAP by:
		-Placing more emphasis on risk of loss when determining a controlling financial interest.
		-Reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (VIE).
		-Changing consolidation conclusions for public and private companies in several industries that typically make use of limited partnerships or VIEs.
		The amendments are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. ASU 2015-02 may be applied retrospectively in previously issued financial statements. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
		ASU 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items
		The amendments in ASU 2015-01 eliminate from U.S. GAAP the concept of extraordinary items. Subtopic 225-20, Income Statement - Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions. The FASB heard from stakeholders that the concept of extraordinary items causes uncertainty because it is unclear when an item should be considered both unusual and infrequent. Additionally, some stakeholders said that although users find information about unusual or infrequent events and transactions useful, they do not find the extraordinary item classification and presentation necessary to identify those events and transactions. Other stakeholders noted that it is extremely rare in current practice for a transaction or event to meet the requirements to be presented as an extraordinary item. This ASU will also align more closely U.S. GAAP income statement presentation guidance with IAS 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. A reporting entity also may apply the amendments retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
		ASU 2014-15, Presentation of Financial Statements —Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern
		The FASB has issued ASU No. 2014-15 which is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The Company is currently evaluating the impact of this Statement on its consolidated financial statements.
		ASU 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity
		The FASB has issued ASU No. 2014-13 which will apply to a reporting entity that is required to consolidate a collateralized financing entity under the Variable Interest Entities guidance. The fair value of the financial assets of a collateralized financing entity, as determined under GAAP, may differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. Before this ASU, there was no specific guidance in GAAP on how a reporting entity should account for that difference. The amendments in this ASU provide an alternative to Topic 820, Fair Value Measurement, for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate that difference. The amendments in this ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted as of the beginning of an annual period. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
		ASU 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for shared-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period.
		The FASB has issued ASU No. 2014-12 which requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718, Compensation – Stock Compensation, as it relates to awards with performance conditions that affect vesting to account for such awards. The performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
		ASU No. 2014-09, Revenues from Contracts with Customers (Topic 606)
		The FASB and IASB (the Boards) have issued converged standards on revenue recognition. ASU No. 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. This ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition and most industry-specific guidance. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:
		•	Step 1: Identify the contract(s) with a customer.
		•	Step 2: Identify the performance obligations in the contract.
		•	Step 3: Determine the transaction price.
		•	Step 4: Allocate the transaction price to the performance obligations in the contract.
		•	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
		For a public entity, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. This ASU is to be applied retrospectively, with certain practical expedients allowed. Early application is not permitted. The Company is currently evaluating the impact of this Statement on its consolidated financial statements.

Intangible_Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2015
Intangible Assets [Text Block]	4	Intangible Assets
		As of March 31, 2015 NDA acquisition costs of $25 thousand (December 31, 2014 - $46 thousand) were recorded as intangible assets on the Company’s balance sheet and represent the net book value of the final progress payment related to the acquisition of 100% ownership of Forfivo XL®. The asset is being amortized over its estimated useful life of 39 months. The Company commenced amortization upon commercial launch of the product in October 2012.

Bank_indebtedness

Bank indebtedness	3 Months Ended
	Mar. 31, 2015
Bank indebtedness [Text Block]	5	Bank indebtedness
		The Company's credit facility is subject to review annually and consists of an operating demand line of credit of up to CAD$250 thousand and corporate credits cards of up to CAD$55 thousand. Borrowings under the operating demand line of credit bear interest at the Bank’s prime lending rate plus 2%. The credit facility and term loan (see note 7) are secured by a first ranking movable hypothec on all present and future movable property of the Company and a 50% guarantee by Export Development Canada, a Canadian Crown corporation export credit agency. The terms of the banking agreement require the Company to comply with certain debt service coverage and debt to net worth financial covenants on an annual basis at the end of the Company’s fiscal year. As at March 31, 2015, the Company has not drawn on its credit facility.

Deferred_License_Revenue

Deferred License Revenue	3 Months Ended
	Mar. 31, 2015
Deferred License Revenue [Text Block]	6	Deferred License Revenue
		Deferred license revenue represents upfront payments received for the granting of licenses to the Company’s patents, intellectual property, and proprietary technology, for commercialization. Deferred license revenue is recognized in income over the period where sales of the licensed products will occur.
		Pursuant to the execution of a licensing agreement for Forfivo XL®, IntelGenx received an upfront fee from Edgemont Pharmaceuticals (“Edgemont”) in the first quarter of 2012, which IntelGenx recognized as deferred license revenue. The deferred license revenue is being amortized in income over a period of 39 months, which is the minimum period where sales of Forfivo XL® are expected to be exclusive.
		In the fourth quarter of 2014, Edgemont exercised its right to extend the license for the exclusive marketing of Forfivo XL®. In accordance with the terms for exercising such right, IntelGenx invoiced $1.25 million to Edgemont and recognized the full amount as deferred revenue, to be amortized in income from October 2014 through September 2015.
		As a result of this policy, IntelGenx has a deferred revenue balance of $856 thousand at March 31, 2015 (December 31, 2014 - $1,245 thousand) that has not been recognized as revenue.

Term_loan

Term loan	3 Months Ended
	Mar. 31, 2015
Term loan [Text Block]	7	Term loan
		The Company’s term loan facility consists of CAD$500 thousand bearing interest at the Bank’s prime lending rate plus 2.50%, and CAD$3 million bearing interest at a fixed rate to be determined at drawdown. The term loan is subject to the same security and financial covenants as the bank indebtedness (see note 5).
		The CAD$3 million tranche of the term loan will be disbursed subsequent to meeting certain conditions based upon the Company’s operating cash flow throughout the first six months of 2015 being positive. There is a moratorium on capital repayments for the first 6 months of each drawdown, at which point the term loan will be repayable in monthly instalments over 60 months.
				31-Mar-15	31-Mar-14
				$	$
		Term loan		395	0
		Current portion		39	0
				356	0
		Principal repayments due in each of the next five years are as follows:
		2015	$	20
		2016		79
		2017		79
		2018		79
		2019		79
		Thereafter		59

Capital_Stock

Capital Stock	3 Months Ended
	Mar. 31, 2015
Capital Stock [Text Block]	8	Capital Stock
				March 31,		December 31,
				2015		2014
		Authorized -
		100,000,000 common shares of $0.00001 par value
		20,000,000 preferred shares of $0.00001 par value
		Issued -
		63,465,255 (December 31, 2014 - 63,465,255) common shares	$	635	$	635

Additional_PaidIn_Capital

Additional Paid-In Capital	3 Months Ended
	Mar. 31, 2015
Additional Paid-In Capital [Text Block]	9	Additional Paid-In Capital
		Stock options
		No stock options were exercised during either of the three month periods ended March 31, 2014 or March 31, 2015.
		Compensation expenses for stock-based compensation of $20 thousand and $32 thousand were recorded during the three-month periods ended March 31, 2015 and March 31, 2014 respectively. The entire amount expensed in each of the first quarters of 2015 and 2014 relates to stock options granted to employees and directors. As at March 31, 2015 the Company has $53 thousand (2014 - $194 thousand) of unrecognized stock-based compensation.
		Warrants
		No warrants were exercised during the three month period ended March 31, 2015. During the three month period ended March 31, 2014, a total of 1,666,388 warrants were exercised for 1,666,388 common shares having a par value of $0 thousand in aggregate, for cash consideration of $1,064 thousand, resulting in an increase in additional paid-in capital of $1,064 thousand.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Text Block]	10	Related Party Transactions
		Included in management salaries are $1 thousand (2014 - $15 thousand) for options granted to the Chief Executive Officer and $11 thousand (2014 - $11 thousand) for options granted to the Chief Financial Officer under the 2006 Stock Option Plan and $3 thousand (2014 - $3 thousand) for options granted to non-employee directors.
		Also included in management salaries are director fees of $40 thousand (2014 - $22 thousand).
		The above related party transactions have been measured at the exchange amount which is the amount of the consideration established and agreed to by the related parties.

Basic_and_Diluted_Loss_Per_Com

Basic and Diluted Loss Per Common Share	3 Months Ended
	Mar. 31, 2015
Basic and Diluted Loss Per Common Share [Text Block]	11	Basic and Diluted Loss Per Common Share
		Basic and diluted loss per common share is calculated based on the weighted average number of shares outstanding during the period. The warrants, share-based compensation and convertible notes have been excluded from the calculation of diluted loss per share since they are anti-dilutive.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Text Block]	12	Subsequent Events
		Subsequent to the end of the quarter, on April 24, 2015 IntelGenx executed an agreement to lease approximately 17,000 square feet in a property located at 6420 Abrams, St-Laurent, Quebec (the “Lease”). The Lease has a 10 year and 6 month term commencing on September 1, 2015 and IntelGenx has retained two options to extend the Lease, with each option being for an additional five years. Under the terms of the Lease IntelGenx will be required to pay base rent of approximately CAD$110 thousand (approximately $87 thousand) per year, which will increase at a rate of CAD$0.25 ($0.20) per square foot every two years. IntelGenx plans to use the newly leased space to manufacture its oral film VersaFilm™ products, to enlarge its research and development capabilities, and for administration purposes.
		On April 28, 2015 IntelGenx executed an agreement for the construction of manufacturing facilities, laboratories, and offices within the property located at 6420 Abrams, St-Laurent, Quebec, at an aggregate cost of CAD$2.9 million (approximately $2.3 million). IntelGenx plans to fund this project from cash on hand. Construction is anticipated to be completed in Q3, 2015.

Summary_of_Significant_Account

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
ASU 2015-02, Consolidation (Topic 810) Amendments to the Consolidation Analysis [Policy Text Block]		ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis
		The amendments in ASU 2015-02 are intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures. The new standard reduces the number of consolidation models and improves current GAAP by:
		-Placing more emphasis on risk of loss when determining a controlling financial interest.
		-Reducing the frequency of the application of related-party guidance when determining a controlling financial interest in a variable interest entity (VIE).
		-Changing consolidation conclusions for public and private companies in several industries that typically make use of limited partnerships or VIEs.
		The amendments are effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. ASU 2015-02 may be applied retrospectively in previously issued financial statements. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
ASU 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20) Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items [Policy Text Block]		ASU 2015-01, Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items
		The amendments in ASU 2015-01 eliminate from U.S. GAAP the concept of extraordinary items. Subtopic 225-20, Income Statement - Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions. The FASB heard from stakeholders that the concept of extraordinary items causes uncertainty because it is unclear when an item should be considered both unusual and infrequent. Additionally, some stakeholders said that although users find information about unusual or infrequent events and transactions useful, they do not find the extraordinary item classification and presentation necessary to identify those events and transactions. Other stakeholders noted that it is extremely rare in current practice for a transaction or event to meet the requirements to be presented as an extraordinary item. This ASU will also align more closely U.S. GAAP income statement presentation guidance with IAS 1, Presentation of Financial Statements, which prohibits the presentation and disclosure of extraordinary items. The amendments are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. A reporting entity also may apply the amendments retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
ASU 2014-15, Presentation of Financial Statements Going Concern (Subtopic 205-40) Disclosure of Uncertainties about an Entitys Ability to Continue as a Going Concern [Policy Text Block]		ASU 2014-15, Presentation of Financial Statements —Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern
		The FASB has issued ASU No. 2014-15 which is intended to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and to provide related footnote disclosures. This ASU provides guidance to an organization’s management, with principles and definitions that are intended to reduce diversity in the timing and content of disclosures that are commonly provided by organizations today in the financial statement footnotes. The amendments are effective for annual periods ending after December 15, 2016, and interim periods within annual periods beginning after December 15, 2016. Early application is permitted for annual or interim reporting periods for which the financial statements have not previously been issued. The Company is currently evaluating the impact of this Statement on its consolidated financial statements.
ASU 2014-13, Consolidation (Topic 810) Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity [Policy Text Block]		ASU 2014-13, Consolidation (Topic 810): Measuring the Financial Assets and the Financial Liabilities of a Consolidated Collateralized Financing Entity
		The FASB has issued ASU No. 2014-13 which will apply to a reporting entity that is required to consolidate a collateralized financing entity under the Variable Interest Entities guidance. The fair value of the financial assets of a collateralized financing entity, as determined under GAAP, may differ from the fair value of its financial liabilities even when the financial liabilities have recourse only to the financial assets. Before this ASU, there was no specific guidance in GAAP on how a reporting entity should account for that difference. The amendments in this ASU provide an alternative to Topic 820, Fair Value Measurement, for measuring the financial assets and the financial liabilities of a consolidated collateralized financing entity to eliminate that difference. The amendments in this ASU are effective for public business entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is permitted as of the beginning of an annual period. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
ASU 2014-12, Compensation Stock Compensation (Topic 718) Accounting for shared-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period. [Policy Text Block]		ASU 2014-12, Compensation – Stock Compensation (Topic 718): Accounting for shared-based payments when the terms of an award provide that a performance target could be achieved after the requisite service period.
		The FASB has issued ASU No. 2014-12 which requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718, Compensation – Stock Compensation, as it relates to awards with performance conditions that affect vesting to account for such awards. The performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. Earlier adoption is permitted. The adoption of this Statement is not expected to have a material effect on the Company`s financial position or results of operations.
ASU No. 2014-09, Revenues from Contracts with Customers (Topic 606) [Policy Text Block]		ASU No. 2014-09, Revenues from Contracts with Customers (Topic 606)
		The FASB and IASB (the Boards) have issued converged standards on revenue recognition. ASU No. 2014-09 affects any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. This ASU will supersede the revenue recognition requirements in Topic 605, Revenue Recognition and most industry-specific guidance. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:
		•	Step 1: Identify the contract(s) with a customer.
		•	Step 2: Identify the performance obligations in the contract.
		•	Step 3: Determine the transaction price.
		•	Step 4: Allocate the transaction price to the performance obligations in the contract.
		•	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
		For a public entity, the amendments in this ASU are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. This ASU is to be applied retrospectively, with certain practical expedients allowed. Early application is not permitted. The Company is currently evaluating the impact of this Statement on its consolidated financial statements.

Term_loan_Tables

Term loan (Tables)	3 Months Ended
	Mar. 31, 2015
Term loan [Table Text Block]				31-Mar-15	31-Mar-14
				$	$
		Term loan		395	0
		Current portion		39	0
				356	0
Term loan principal repayments [Table Text Block]		2015	$	20
		2016		79
		2017		79
		2018		79
		2019		79
		Thereafter		59

Capital_Stock_Tables

Capital Stock (Tables)	3 Months Ended
	Mar. 31, 2015
Schedule of Stock by Class [Table Text Block]				March 31,		December 31,
				2015		2014
		Authorized -
		100,000,000 common shares of $0.00001 par value
		20,000,000 preferred shares of $0.00001 par value
		Issued -
		63,465,255 (December 31, 2014 - 63,465,255) common shares	$	635	$	635

Intangible_Assets_Narrative_De

Intangible Assets (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
	M
Intangible Assets 1	$25
Intangible Assets 2	$46
Intangible Assets 3	100.00%
Intangible Assets 4	39

Bank_indebtedness_Narrative_De

Bank indebtedness (Narrative) (Details) (CAD)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Bank Indebtedness 1	250
Bank Indebtedness 2	55
Bank Indebtedness 3	2.00%
Bank Indebtedness 4	50.00%

Deferred_License_Revenue_Narra

Deferred License Revenue (Narrative) (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
	M
Deferred License Revenue 1	39
Deferred License Revenue 2	$1,250,000
Deferred License Revenue 3	856,000
Deferred License Revenue 4	$1,245,000

Term_loan_Narrative_Details

Term loan (Narrative) (Details) (CAD)	3 Months Ended
	Mar. 31, 2015
	M
Term Loan 1	500,000
Term Loan 2	2.50%
Term Loan 3	3,000,000
Term Loan 4	3,000,000
Term Loan 5	6
Term Loan 6	60

Additional_PaidIn_Capital_Narr

Additional Paid-In Capital (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015
Additional Paid-in Capital 1	$20
Additional Paid-in Capital 2	32
Additional Paid-in Capital 3	53
Additional Paid-in Capital 4	194
Additional Paid-in Capital 5	1,666,388
Additional Paid-in Capital 6	1,666,388
Additional Paid-in Capital 7	0
Additional Paid-in Capital 8	1,064
Additional Paid-in Capital 9	$1,064

Related_Party_Transactions_Nar

Related Party Transactions (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Related Party Transactions 1	$1
Related Party Transactions 2	15
Related Party Transactions 3	11
Related Party Transactions 4	11
Related Party Transactions 5	3
Related Party Transactions 6	3
Related Party Transactions 7	40
Related Party Transactions 8	$22

Subsequent_Events_Narrative_De

Subsequent Events (Narrative) (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2015
	USD ($)	CAD
	M
	Y
Subsequent Events 1	17,000	17,000
Subsequent Events 2	10	10
Subsequent Events 3	6	6
Subsequent Events 4		110,000
Subsequent Events 5	87,000
Subsequent Events 6		0.25
Subsequent Events 7	0.2
Subsequent Events 8		2,900,000
Subsequent Events 9	$2,300,000

Term_loan_Details

Term loan (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Term Loan Term Loan 1	$395
Term Loan Term Loan 2	0
Term Loan Term Loan 3	39
Term Loan Term Loan 4	0
Term Loan Term Loan 5	356
Term Loan Term Loan 6	$0

Term_loan_principal_repayments

Term loan principal repayments (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Term Loan Term Loan Principal Repayments 1	$20
Term Loan Term Loan Principal Repayments 2	79
Term Loan Term Loan Principal Repayments 3	79
Term Loan Term Loan Principal Repayments 4	79
Term Loan Term Loan Principal Repayments 5	79
Term Loan Term Loan Principal Repayments 6	$59

Schedule_of_Stock_by_Class_Det

Schedule of Stock by Class (Details) (USD $)	3 Months Ended
	Mar. 31, 2015
Capital Stock Schedule Of Stock By Class 2	100,000,000
Capital Stock Schedule Of Stock By Class 3	$0.00
Capital Stock Schedule Of Stock By Class 4	20,000,000
Capital Stock Schedule Of Stock By Class 5	0.00001
Capital Stock Schedule Of Stock By Class 7	63,465,255
Capital Stock Schedule Of Stock By Class 8	63,465,255
Capital Stock Schedule Of Stock By Class 9	635,000
Capital Stock Schedule Of Stock By Class 10	$635,000